BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12187164)

  • 1. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations.
    Bach PB; Guadagnoli E; Schrag D; Schussler N; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-19-25. PubMed ID: 12187164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing comorbidity using claims data: an overview.
    Klabunde CN; Warren JL; Legler JM
    Med Care; 2002 Aug; 40(8 Suppl):IV-26-35. PubMed ID: 12187165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
    Warren JL; Klabunde CN; Schrag D; Bach PB; Riley GF
    Med Care; 2002 Aug; 40(8 Suppl):IV-3-18. PubMed ID: 12187163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying radiation therapy using SEER-Medicare-linked data.
    Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
    Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring complications of cancer treatment using the SEER-Medicare data.
    Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
    Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
    Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
    J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for cancer related health services research using a linked Medicare-tumor registry database.
    Potosky AL; Riley GF; Lubitz JD; Mentnech RM; Kessler LG
    Med Care; 1993 Aug; 31(8):732-48. PubMed ID: 8336512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts.
    Coker AL; Du XL; Fang S; Eggleston KS
    Gynecol Oncol; 2006 Aug; 102(2):278-84. PubMed ID: 16434087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating health care costs related to cancer treatment from SEER-Medicare data.
    Brown ML; Riley GF; Schussler N; Etzioni R
    Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources.
    Schrag D; Bach PB; Dahlman C; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-96-103. PubMed ID: 12187174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography.
    Polsky D; Armstrong KA; Randall TC; Ross RN; Even-Shoshan O; Rosenbaum PR; Silber JH
    Health Serv Res; 2006 Dec; 41(6):2201-18. PubMed ID: 17116116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the SEER--Medicare Health Outcomes Survey linked dataset.
    Ambs A; Warren JL; Bellizzi KM; Topor M; Haffer SC; Clauser SB
    Health Care Financ Rev; 2008; 29(4):5-21. PubMed ID: 18773611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological issues in the use of administrative claims data to study surveillance after cancer treatment.
    Butler Nattinger A; Schapira MM; Warren JL; Earle CC
    Med Care; 2002 Aug; 40(8 Suppl):IV-69-74. PubMed ID: 12187171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The health care experience of patients with cancer during the last year of life: Analysis of the SEER-CAHPS data set.
    Halpern MT; Urato MP; Kent EE
    Cancer; 2017 Jan; 123(2):336-344. PubMed ID: 27654842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic status and survival in older patients with melanoma.
    Reyes-Ortiz CA; Goodwin JS; Freeman JL; Kuo YF
    J Am Geriatr Soc; 2006 Nov; 54(11):1758-64. PubMed ID: 17087705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.